Last edition
News about Biotechnology
Bayer announced today the initiation of the FINEARTS-HF study, a multicenter, randomized, double-blind, placebo-controlled Phase III study to evaluate the efficacy and safety of finerenone on morbidity and mortality in patients suffering from symptomatic heart failure
Biotechnology | 16/06/2020 | By Darshana | 584
Following National Pharmaceutical Pricing Authority (NPPA) directive to address the demand of tocilizumab injection in government hospitals in Gujarat for the treatment of COVID-19 patients, the Mumbai-based pharmaceutical major Cipla Ltd has renewed its supply by releasing another batch of 700 tocilizumab injections to Gujarat
Biotechnology | 11/06/2020 | By Darshana | 968
Lupin: U.S. FDA Grants Mexiletine Orphan Drug Designation
Pharma major Lupin Limited (Lupin) is announced today that the US Food and Drug Administration (U.S. FDA) has granted Orphan Drug Designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders
Biotechnology | 08/06/2020 | By Darshana | 675
FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
Today the U.S. Food and Drug Administration took steps to further support the development of COVID-19 tests for at-home self-collection by including a voluntary EUA template for at-home sample collection kits to its website
Biotechnology | 01/06/2020 | By Darshana | 162
Today the U.S. Food and Drug Administration took a new step to support the agency's evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel. Reference panels are an additional step to ensure the quality of the tests, validation of new assays, test calibration, and monitoring of assay performance
Biotechnology | 28/05/2020 | By Darshana | 170
ICMR to present fully indigenous diagnostic platform for COVID-19
The Indian Council of Medical Research (ICMR) has validated a fully indigenous diagnostic platform for COVID-19 diagnosis.
Biotechnology | 25/05/2020 | By Darshana | 277
FDA Provides Promised Transparency for Antibody Tests
Today, the U.S. Food and Drug Administration posted a list of antibody tests that are being removed from the notification list of tests being offered under the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency
Biotechnology | 22/05/2020 | By Darshana | 178
BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment
Bellus a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it will convene a virtual Key Opinion Leader (KOL) meeting to discuss the chronic cough landscape on Wednesday, May 27, 2020 at 9:00 a.m. EDT
Biotechnology | 15/05/2020 | By Darshana | 331
ICMR notifies NIMHANS as mentor institution for RT-PCR test protocol for COVID-19
The National Institute of Mental Health and Neuro Sciences (NIMHANS) has been notified by the Indian Council of Medical Research (ICMR) and the Medical Council of India (MCI) as the mentor institution for RT-PCR (Reverse transcription-polymerase chain reaction) test
Biotechnology | 10/05/2020 | By Darshana | 329
Hydroxychloroquine and Chloroquine Marketto more than Double in 2020 ? TechSci Research
Increase in prevalence of COVID-19 to drive demand for hydroxychloroquine and chloroquine across the globe
Biotechnology | 29/04/2020 | By Darshana | 181
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy